The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell

Antiviral Research

Volumn 66, Issue 2-3, 2005, Pages 103-110

  Talarico, L B ^a   Pujol, C A ^a   Zibetti, R G M ^b   Faria P C S ^b   Noseda, M D ^b   Duarte, M E R ^b   Damonte, E B ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Antiviral activity; Dengue virus; Flaviviruses; Sulfated polysaccharides; Viral entry

Indexed keywords

CARRAGEENAN; DEXTRO LEVO GALACTAN; GALACTAN; KAPPA IOTA NU CARRAGEENAN G3D; POLYSACCHARIDE SULFATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CELL STRAIN HEPG2; CELL TYPE; CONTROLLED STUDY; DENGUE VIRUS; FIBROBLAST; HOST CELL; HUMAN; HUMAN CELL; IC 50; INSECT CELL; MOSQUITO; NONHUMAN; PREPUCE; PRIORITY JOURNAL; SEAWEED; VERO CELL; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DENGUE VIRUS; GALACTANS; MICROBIAL SENSITIVITY TESTS; POLYSACCHARIDES; SEAWEED; SULFATES; VERO CELLS;

ALGAE; CRYPTONEMIA CRENULATA; DENGUE VIRUS; GYMNOGONGRUS GRIFFITHSIAE;

EID: 19344365993     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2005.02.001     Document Type: Article

References (40)

1. R. Anderson, A.D. King, and B.L. Innis Correlation of E protein binding with cell susceptibility to dengue 4 virus infection J. Gen. Virol. 73 1992 2155 2159
2. H. Bielefeldt-Ohmann Analysis of antibody-independent binding of dengue viruses and dengue virus envelope protein to human myelomonocytic cells and B lymphocytes Virus Res. 57 1998 63 79
3. N. Charlier, P. Leyssen, E. De Clercq, and J. Neyts Rodent models for the study of therapy against flavivirus infections Antivir. Res. 63 2004 67 77
4. Y. Chen, T. Maguire, and R.M. Marks Demonstration of binding of dengue virus envelope protein to target cells J. Virol. 70 1996 8765 8772
5. Y. Chen, T. Maguire, R.E. Hileman, J.R. Fromm, J.D. Esko, R.J. Linhardt, and R.M. Marks Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate Nat. Med. 3 1997 866 871
6. J.M. Crance, N. Scaramozzino, A. Jouan, and D. Garin Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses Antivir. Res. 58 2003 73 79
7. E.B. Damonte, M.C. Matulewicz, and A.S. Cerezo Sulfated seaweed polysaccharides as antiviral agents Curr. Med. Chem. 11 2004 2399 2419
8. E.B. Damonte, C.A. Pujol, and C.E. Coto Prospects for the therapy and prevention of dengue virus infections Adv. Virus Res. 63 2004 239 285
9. C.C. Daughaday, W.E. Brandt, J.M. McCown, and P.K. Russell Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors Infect. Immun. 32 1981 469 473
10. M.S. Diamond, M. Zachariah, and E. Harris Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA Virology 304 2002 211 221
11. B. Gabrielsen, M.J. Phelan, L. Barthel-Rosa, C. See, J.W. Huggins, D.F. Kefauver, T.P. Monath, M.A. Ussery, G.N. Chmurny, E.M. Schubert, K. Upadhya, C. Kwong, D.A. Carter, J.A. Secrist III, J.J. Kirsi, W.M. Shannon, R.W. Sidwell, G.D. Kini, and R.K. Robins Synthesis and antiviral evaluation of N-carboxamidine-substituted analogues of 1-β-d-ribofuranosyl-1,2,4- triazole-3-carboxamidine hydrochloride J. Med. Chem. 35 1992 3231 3238
12. R. Germi, J.M. Crance, D. Garin, J. Guimet, H. Lortat-Jacob, R.W.H. Ruigrok, J.P. Zarski, and E. Drouet Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus Virology 292 2002 162 168
13. D.J. Gubler Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century Trends Microbiol. 10 2002 100 103
14. T. Hase, P.L. Summers, and K.H. Eckels Flavivirus entry into cultured mosquito cells and human peripheral blood monocytes Arch. Virol. 104 1989 129 143
15. F.X. Heinz, G. Auer, K. Stiasny, H. Holzmann, C. Mandl, F. Guirakhoo, and C. Kunz The interactions of the flavivirus envelope proteins: implications for virus entry and release Arch. Virol. 9 Suppl. 1994 339 348
16. P. Hilgard, and R. Stockert Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes Hepatology 32 2000 1069 1077
17. S.L. Hung, P.L. Lee, H.W. Chen, L.K. Chen, C.L. Kao, and C.C. King Analysis of the steps involved in dengue virus entry into host cells Virology 257 1999 156 167
18. W.C. Koff, J.L. Elm Jr., and S.B. Halstead Antiviral effects of ribavirin and 6-mercapto-9-tetrahydro-2-furylpurine against dengue viruses in vitro Antivir. Res. 2 1982 69 79
19. P. Leyssen, E. De Clercq, and J. Neyts Perspectives for the treatment of infections with Flaviviridae Clin. Microbiol. Rev. 13 2000 67 82
20. H.Y. Lim, and M.L. Ng A different mode of entry by dengue-2 neutralisation escape mutant virus Arch. Virol. 144 1999 989 995
21. Y.-L. Lin, H.-Y. Lei, Y.-S. Lin, T.-M. Yeh, S.-H. Chen, and H.-S. Liu Heparin inhibits dengue-2 virus infection of five human liver cell lines Antivir. Res. 56 2002 93 96
22. B.D. Lindenbach, and C.M. Rice Flaviviridae: the viruses and their replication D.M. Knipe P.M. Howley Fundamental Virology 2001 Lippincott Williams & Wilkins Philadelphia 589 639
23. P. Marianneau, F. Mégret, R. Olivier, D.M. Morens, and V. Deubel Dengue 1 virus binding to human hepatoma HepG2 and simian Vero cell surfaces differs J. Gen. Virol. 77 1996 2547 2554
24. W. Markland, T..J. McQuaid, J. Jain, and A.D. Kwong Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon Antimicrob. Agents Chemother. 44 2000 859 866
25. R.M. Marks, H. Lu, R. Sundaresan, T. Toida, A. Suzuki, T. Imanari, M.J. Hernáiz, and R.J. Linhardt Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors J. Med. Chem. 44 2001 2178 2187
26. J.J. Martínez-Barragán, and R.M. del Angel Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection J. Virol. 75 2001 7818 7827
27. W.J.H. McBride, and H. Bielefeldt-Ohmann Dengue viral infections: pathogenesis and epidemiology Microbes Infect. 2 2000 1041 1050
28. M.P. Miagostovich, F.B. dos Santos, T.S. de Simone, E.V. Costa, A.M.B. Filippis, H.G. Schatzmayr, and R.M.R. Nogueira Genetic characterization of dengue virus type 3 isolates in the State of Rio de Janeiro, 2001 Braz. J. Med. Biol. Res. 35 2002 869 872
29. M.M.B. Moreno-Altamirano, F.J. Sánchez-García, and M.L. Muñoz Non Fc receptor-mediated infection of human macrophages by dengue virus serotype 2 J. Gen. Virol. 83 2002 1123 1130
30. M.L. Muñoz, A. Cisneros, J. Cruz, P. Das, R. Tovar, and A. Ortega Putative dengue virus receptors from mosquito cells FEMS Microbiol. Lett. 168 1998 251 258
31. L. Ono, W. Wollinger, I.M. Rocco, T.L.M. Coimbra, P.A.J. Gorin, and M.R. Sierakowski In vitro and in vivo antiviral properties of sulphated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain) Antivir. Res. 60 2003 201 208
32. C.A. Pujol, J.M. Estévez, M.J. Carlucci, M. Ciancia, A.S. Cerezo, and E.B. Damonte Novel dl-galactan hybrids from the red seaweed Gymnogongrus torulosus are potent inhibitors of herpes simplex virus and dengue virus Antivir. Chem. Chemother. 13 2002 83 89
33. J. Ramos-Castañeda, J.L. Imbert, B.L. Barron, and C. Ramos A 65-kDa trypsin sensible membrane cell protein as a possible receptor for dengue virus in cultured neuroblastoma cells J. Neurovirol. 3 1997 435 440
34. V.B. Randolph, and V. Stollar Low pH-induced cell fusion in flavivirus-infected Aedes albopictus cell cultures J. Gen. Virol. 71 1990 1845 1850
35. J.S. Salas-Benito, and R.M. del Angel Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus J. Virol. 71 1997 7246 7252
36. S. Shigeta, S. Mori, E. Kodama, J. Kodama, K. Takahashi, and T. Yamase Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates Antivir. Res. 58 2003 265 271
37. D. Spillmann Heparan sulfate: anchor for viral intruders? Biochimie 83 2001 811 817
38. L.B. Talarico, R.G.M. Zibetti, P.C.S. Faría, L.A. Scolaro, M.E.R. Duarte, M.D. Noseda, C.A. Pujol, and E.B. Damonte Anti-herpes simplex virus activity of sulfated galactans from the red seaweeds Gymnogongrus griffithsiae and Cryptonemia crenulata Int. J. Biol. Macromol. 34 2004 63 71
39. H.-Y. Wei, L.-F. Jiang, D.-Y. Fang, and H.-Y. Guo Dengue virus type 2 infects human endothelial cells through binding of the viral envelope glycoprotein to cell surface polypeptides J. Gen. Virol. 84 2003 3095 3098
40. M. Witvrouw, and E. De Clercq Sulfated polysaccharides extracted from sea algae as potential antiviral drugs Gen. Pharmacol. 29 1997 497 511